Thanks for the info Fuzzy! Nice find!

Announced today for those of you who don't follow Zenith Epigenetics closely. From Bear's post:

Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial

Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial

https://www.zenithepigenetics.com/newsroom/news-releases.html?article=55

Phase 2b Triple Negative Breast Cancer (TNBC) trial in combination with the PARP inhibitor TALZENNA (talazoparib), conducted in collaboration with Pfizer and Newsoara Biopharma. Zenith and Newsoara are the trial sponsors.

https://agoracom.com/ir/ZenithEpigenetics/forums/discussion/topics/778104-zenith-epigenetics-announces-initiation-of-a-phase-2b-triple-negative-breast-cancer-tnbc-clinical-trial/messages/2356755#message

Would love to see Pfizer or a consortium take us out on both Zenith and Resverlogix! Let's end the misery for us retail guys and gals...and put Don on a Hawaiian beach for six months of the year! These drugs need to get to the market!